APA (7th ed.) Citation

Naqash, M., Tariq, A., Shayan, S., Sargani, S. M., Raza, M. A., Khan, N. N., . . . Uhlmann, D. (2026). Fibroblast Growth Factor 21 Analogues Improve Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis: An Updated Systematic Review and Meta‐Analysis. International Journal of Hepatology, 2026, 1. https://doi.org/10.1155/ijh/7391450

Chicago Style (17th ed.) Citation

Naqash, Muhammad, et al. "Fibroblast Growth Factor 21 Analogues Improve Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis: An Updated Systematic Review and Meta‐Analysis." International Journal of Hepatology 2026 (2026): 1. https://doi.org/10.1155/ijh/7391450.

MLA (9th ed.) Citation

Naqash, Muhammad, et al. "Fibroblast Growth Factor 21 Analogues Improve Fibrosis in Metabolic Dysfunction–Associated Steatohepatitis: An Updated Systematic Review and Meta‐Analysis." International Journal of Hepatology, vol. 2026, 2026, p. 1, https://doi.org/10.1155/ijh/7391450.